UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000031285 |
|---|---|
| Receipt number | R000035715 |
| Scientific Title | A phase II study of weekly nab-paclitaxel plus ramucirumab in patients with previously treated advanced gastric cancer |
| Date of disclosure of the study information | 2018/02/14 |
| Last modified on | 2025/12/24 10:03:50 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/02/13 19:35:01 | ||
| 2 | Update | 2024/10/07 21:38:22 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
| 3 | Update | 2024/10/09 09:29:47 | Recruitment status Date of IRB Last follow-up date |
|
| 4 | Update | 2024/10/09 09:36:33 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 5 | Update | 2025/12/08 08:54:41 | Target sample size |
|
| 6 | Update | 2025/12/08 09:35:46 | Key inclusion criteria Key inclusion criteria |
|
| 7 | Update | 2025/12/24 09:55:24 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 8 | Update | 2025/12/24 10:03:50 | Recruitment status Last follow-up date |
